BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25956924)

  • 1. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.
    Ormseth MJ; Chung CP; Oeser AM; Connelly MA; Sokka T; Raggi P; Solus JF; Otvos JD; Stein CM
    Arthritis Res Ther; 2015 May; 17(1):117. PubMed ID: 25956924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
    Bartlett DB; Connelly MA; AbouAssi H; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
    Arthritis Res Ther; 2016 Apr; 18():86. PubMed ID: 27067270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of
    Fuertes-Martín R; Taverner D; Vallvé JC; Paredes S; Masana L; Correig Blanchar X; Amigó Grau N
    J Proteome Res; 2018 Nov; 17(11):3730-3739. PubMed ID: 30353728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
    Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
    Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Length and Coronary Atherosclerosis in Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Oeser AM; Bian A; Gebretsadik T; Shintani A; Raggi P; Stein CM
    J Rheumatol; 2016 Aug; 43(8):1469-74. PubMed ID: 27252422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
    J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
    Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
    Rho YH; Solus J; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):535-41. PubMed ID: 20890983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
    Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
    J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis.
    Ton E; Bakker MF; Verstappen SM; Ter Borg EJ; van Albada-Kuipers IA; Schenk Y; van der Veen MJ; Bijlsma JW; Jacobs JW;
    J Rheumatol; 2012 Jan; 39(1):22-7. PubMed ID: 22002014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
    Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
    Chung CP; Oeser A; Raggi P; Sokka T; Pincus T; Solus JF; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2010 Aug; 37(8):1633-8. PubMed ID: 20516025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.
    Dullaart RP; Gruppen EG; Connelly MA; Lefrandt JD
    Clin Biochem; 2015 Nov; 48(16-17):1045-7. PubMed ID: 26129880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.
    Xue L; Tao L; Li X; Wang Y; Wang B; Zhang Y; Gao N; Dong Y; Xu N; Xiong C; Zhou T; Liu Z; Liu H; He J; Li K; Geng Y; Li M
    Sci Rep; 2021 Aug; 11(1):16903. PubMed ID: 34413382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.